Bafna Pharmaceuticals Limited — Others, 05-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Bafna Pharmaceuticals has announced a board meeting on the financial results for the quarter and half-year. The company’s Registrar and Share Transfer Agent, Cameo Corporate Services, has confirmed that all securities received for dematerialisation during the quarter were processed, accepted or rejected as appropriate, and listed on stock exchanges. Security certificates were cancelled after verification, and dematerialisation details have been updated in the share registry. This ensures smooth electronic trading of the company’s shares and maintains regulatory compliance, benefiting shareholders through streamlined shareholding records.